Using inertial sensors, a research group has managed to measure horse movement as well as the timing of the hoof's contact with the ground very accurately. Using this new method, veterinarians will be able to analyse the movement patterns of horses with lameness much better than before.
Understanding how the human body recognizes damaged DNA and initiates repair fascinates Michael Feig, professor of biochemistry and molecular biology at Michigan State University. Feig studies the proteins that recognize defective ...
Henkel-sponsored adaptive athlete Monster Mike Schultz showcased his athletic prowess and self-taught engineering skills when he took home the gold in the Moto X Adaptive Final at X Games Los Angeles 2013 on August 3. Throughout the competition, Schultz - Popular Science magazine 2013 Invention Award winner and an above-the-knee amputee - sported the prosthetic leg that he designed and built.
CoAlign Innovations, Inc. Announces FDA Clearance of AccuLIF® Expandable Interbody Device Product Line for Lateral Surgical ApproachesAugust 19, 2013 8:30 am | by Business Wire | News | Comments
CoAlign Innovations, Inc. announced today that its AccuLIF® XL lateral expandable interbody fusion devices have received marketing clearance from the United States Food and Drug Administration. This new product line addresses fusion procedures employing the lateral approach.
C. R. Bard, Inc. has announced that it has entered into a definitive agreement to acquire privately-held Medafor, Inc., a leading developer and supplier of plant based hemostatic agents for the purchase price of $200 million paid at closing, expected to occur later this year, and future contingent payments up to an additional $80 million based on specific revenue-based milestones through June 30, 2015.
STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it has received regulatory approval to market its Visian@ Implantable Collamer@ Lens (ICLT) with CentraFLOWT technology from the CDSCO in India.
Of the many military medical advances that have resulted during the wars in Iraq and Afghanistan, one breakthrough has been in the treatments for burn patients, according to military and civilian medical experts attending a Defense Department-sponsored conference held in Fort Lauderdale, Fla.
Now engineers at Imperial College in London have developed an EEG device that can be worn inside the ear, like a hearing aid. They say the device will allow scientists to record EEGs for several days at a time; this would allow doctors to monitor patients who have regularly recurring problems like seizures or microsleep.
A Rice University laboratory has improved upon its ability to determine molecular structures in three dimensions in ways that challenge long-used standards. By measuring the vibrations between atoms using femtosecond-long laser pulses, the Rice lab is able to discern the positions of atoms within molecules without the restrictions imposed by X-ray diffraction and nuclear magnetic resonance imaging.
Berkeley Lab scientists have helped to develop a tiny chip that has big potential for quickly determining whether someone has been exposed to dangerous levels of ionizing radiation. The first-of-its-kind chip has an array of nanosensors that measure the concentrations of proteins that change after radiation exposure.
A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University has received a $5.6 million grant award from the United States Food and Drug Administration (FDA) to use its Organs-on-Chips technology for a novel application of keen interest to national security and health officials: to test human physiological responses to radiation, and to evaluate drugs designed to counter those effects.
Atherosclerosis is a major cardiovascular disease involving accumulations of lipids, white blood cells, and other materials on the inside of artery walls. Since the calcification found in the advanced stage of atherosclerosis dramatically enhances the mechanical properties of the plaque, restoring the original lumen of the artery remains a challenge.
Researchers at the University of Georgia are developing a new treatment technique that uses nanoparticles to reprogram immune cells so they are able to recognize and attack cancer. The findings were published recently in the early online edition of ACS Nano.
David D. Nolte, a professor in Purdue's Department of Physics, and his collaborators Ran An, a graduate student in physics, and John J. Turek in the Department of Basic Medical Sciences have created a technique called BioDynamic Imaging that measures the activity inside cancer biopsies, or samples of cells.
Innovative point-of-care tests that can assist operators with capturing test results and “reading” for a specific diagnosis are driving revenue growth of the lateral flow test category, according to Kalorama Information. Driven by these enhancements and others, the lateral flow point of care testing market (LF-POC) grew to $3.6 billion worldwide in 2012.